These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19756586)

  • 21. Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
    Ribeiro MA; Paula CR
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):71-5. PubMed ID: 16839736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of hyphae formation and SIR2 expression in Candida albicans treated with fresh Allium sativum (garlic) extract.
    Low CF; Chong PP; Yong PV; Lim CS; Ahmad Z; Othman F
    J Appl Microbiol; 2008 Dec; 105(6):2169-77. PubMed ID: 19120662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining Candida albicans stationary phase by cellular and DNA replication, gene expression and regulation.
    Uppuluri P; Chaffin WL
    Mol Microbiol; 2007 Jun; 64(6):1572-86. PubMed ID: 17555439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key physiological differences in Candida albicans CDR1 induction by steroid hormones and antifungal drugs.
    Larsen B; Anderson S; Brockman A; Essmann M; Schmidt M
    Yeast; 2006 Aug; 23(11):795-802. PubMed ID: 16921553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletions of the endocytic components VPS28 and VPS32 in Candida albicans lead to echinocandin and azole hypersensitivity.
    Cornet M; Gaillardin C; Richard ML
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3492-5. PubMed ID: 17005841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multilocus sequence typing confirms synonymy but highlights differences between Candida albicans and Candida stellatoidea.
    Jacobsen MD; Boekhout T; Odds FC
    FEMS Yeast Res; 2008 Aug; 8(5):764-70. PubMed ID: 18547330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29.
    Shekhar-Guturja T; Tebung WA; Mount H; Liu N; Köhler JR; Whiteway M; Cowen LE
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7468-7480. PubMed ID: 27736764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Candida albicans Ddr48 protein is essential for filamentation, stress response, and confers partial antifungal drug resistance.
    Dib L; Hayek P; Sadek H; Beyrouthy B; Khalaf RA
    Med Sci Monit; 2008 Jun; 14(6):BR113-121. PubMed ID: 18509269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of deoxyribonucleic acid microarray analysis to the study of azole antifungal resistance in Candida albicans.
    Barker KS; Rogers PD
    Methods Mol Med; 2005; 118():45-56. PubMed ID: 15888934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of proteomic analysis to the study of azole antifungal resistance in Candida albicans.
    Hooshdaran MZ; Hilliard GM; Rogers PD
    Methods Mol Med; 2005; 118():57-70. PubMed ID: 15888935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity.
    Borate HB; Sawargave SP; Chavan SP; Chandavarkar MA; Iyer R; Tawte A; Rao D; Deore JV; Kudale AS; Mahajan PS; Kangire GS
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4873-8. PubMed ID: 21757344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans.
    Prasad T; Hameed S; Manoharlal R; Biswas S; Mukhopadhyay CK; Goswami SK; Prasad R
    FEMS Yeast Res; 2010 Aug; 10(5):587-96. PubMed ID: 20491944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentially expressed proteins in derivatives of Candida albicans displaying a stable histatin 3-resistant phenotype.
    Fitzgerald-Hughes DH; Coleman DC; O'Connell BC
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2793-800. PubMed ID: 17485506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic mechanisms of retigeric acid B and azoles against Candida albicans.
    Sun LM; Cheng AX; Wu XZ; Zhang HJ; Lou HX
    J Appl Microbiol; 2010 Jan; 108(1):341-8. PubMed ID: 20002912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungals to treat Candida albicans.
    Moudgal V; Sobel J
    Expert Opin Pharmacother; 2010 Aug; 11(12):2037-48. PubMed ID: 20536294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentially-expressed genes in Candida albicans exposed to ε-poly-L-lysine.
    Ye RS; Zhang ZH; Xu HY; Xu F; Aguilar ZP; Xiong YH; Zeng ZL; Wei H
    Biotechnol Lett; 2013 Dec; 35(12):2147-53. PubMed ID: 23974498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. All about CDR transporters: Past, present, and future.
    Prasad R; Balzi E; Banerjee A; Khandelwal NK
    Yeast; 2019 Apr; 36(4):223-233. PubMed ID: 30192990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of multidrug resistance in pathogenic fungi.
    Morschhäuser J
    Fungal Genet Biol; 2010 Feb; 47(2):94-106. PubMed ID: 19665571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans.
    Sharma M; Manoharlal R; Puri N; Prasad R
    Biosci Rep; 2010 Dec; 30(6):391-404. PubMed ID: 20017731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exposure of Candida albicans to antifungal agents affects expression of SAP2 and SAP9 secreted proteinase genes.
    Copping VM; Barelle CJ; Hube B; Gow NA; Brown AJ; Odds FC
    J Antimicrob Chemother; 2005 May; 55(5):645-54. PubMed ID: 15820985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.